Paper8014455
Response to interferon alpha therapy is influenced by the iron content of the liver.
Van Thiel DH and 5 others. J Hepatol, 1994. Cited by 230 papers, by iCite.
Cite this record
ConductScience Library. Response to interferon alpha therapy is influenced by the iron content of the liver. Papers, record 8014455. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8014455
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B | Major topic |
| Interferon-alpha | Major topic |
| Iron | Major topic |
| Liver | Major topic |
| Adult | |
| Alanine Transaminase | |
| Biopsy | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 230 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38169881 | Liver iron overload and fat content analyzed by magnetic resonance contribute to evaluatingthe progression of chronic hepatitis B. | Biomed Rep | 2024 | https://conductscience.org/library/papers/38169881 | PubMed |
| 35126838 | Hepatitis C virus: A critical approach to who really needs treatment. | World J Hepatol | 2022 | https://conductscience.org/library/papers/35126838 | PubMed |
| 32015868 | Treatment of Chronic HCV Infection in Patients With Thalassemia. | Clin Liver Dis (Hoboken) | 2019 | https://conductscience.org/library/papers/32015868 | PubMed |
| 29384977 | Improvement of chronic hepatitis B by iron chelation therapy in a patient with iron overload: A case report. | Medicine (Baltimore) | 2017 | https://conductscience.org/library/papers/29384977 | PubMed |
| 27041937 | Iron, HCV and the liver. | World J Gastroenterol | 1997 | https://conductscience.org/library/papers/27041937 | PubMed |
| 25755436 | Hemochromatosis gene mutations: prevalence and effects on pegylated-interferon and ribavirin therapy response in chronic hepatitis C in sardinia. | J Clin Exp Hepatol | 2012 | https://conductscience.org/library/papers/25755436 | PubMed |
| 21845061 | Effect of hepatic iron concentration and viral factors in chronic hepatitis C-infected patients with thalassemia major, treated with interferon and ribavirin. | Int J Gen Med | 2011 | https://conductscience.org/library/papers/21845061 | PubMed |
| 20927485 | Identification of treatment efficacy-related host factors in chronic hepatitis C by ProteinChip serum analysis. | Mol Med | 2011 | https://conductscience.org/library/papers/20927485 | PubMed |
| 20011735 | The role of iron in the pathophysiology and treatment of chronic hepatitis C. | Can J Gastroenterol | 2009 | https://conductscience.org/library/papers/20011735 | PubMed |
| 19777608 | Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells. | World J Gastroenterol | 2009 | https://conductscience.org/library/papers/19777608 | PubMed |
| 19669262 | The effect of iron depletion on chronic hepatitis C virus infection. | Hepatol Int | 2008 | https://conductscience.org/library/papers/19669262 | PubMed |
| 19418586 | Hyperferritinemia is a risk factor for steatosis in chronic liver disease. | World J Gastroenterol | 2009 | https://conductscience.org/library/papers/19418586 | PubMed |
| 17846887 | Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials. | Dig Dis Sci | 2008 | https://conductscience.org/library/papers/17846887 | PubMed |
| 17729391 | Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance. | World J Gastroenterol | 2007 | https://conductscience.org/library/papers/17729391 | PubMed |
| 17729389 | HFE gene in primary and secondary hepatic iron overload. | World J Gastroenterol | 2007 | https://conductscience.org/library/papers/17729389 | PubMed |
| 16451091 | Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management. | Drugs | 2006 | https://conductscience.org/library/papers/16451091 | PubMed |
| 16094713 | Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C. | World J Gastroenterol | 2005 | https://conductscience.org/library/papers/16094713 | PubMed |
| 15307893 | Synergic effect of chronic hepatitis C infection and beta thalassemia major with marked hepatic iron overload on liver fibrosis: a retrospective cross-sectional study. | BMC Gastroenterol | 2004 | https://conductscience.org/library/papers/15307893 | PubMed |
| 14557859 | Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype. | J Mol Med (Berl) | 2003 | https://conductscience.org/library/papers/14557859 | PubMed |
| 12679924 | Is laparoscopy an advantage in the diagnosis of cirrhosis in chronic hepatitis C virus infection? | World J Gastroenterol | 2003 | https://conductscience.org/library/papers/12679924 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8014455
GET https://conductscience.org/api/papers/v1/8014455/cited_by?page=2